MarketInOut Stock Screener Log In | Sign Up

YD Bio Ltd Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/29/2026 11:15
YD Bio Ltd Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization539.11 mln
Earnings Date11/30/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

68 / 100
Outperforming

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-1,393%
Severely loss-making

ROE

-445
Deeply negative

ROA

-38.42
Deeply negative

Business Description

YD Bio Limited is a Taiwan-based medical company working to improve how serious diseases are diagnosed and treated. Its main areas of work include finding cancer through blood tests and creating new therapies using stem cells and exosomes. The company targets conditions where patients currently have few or no good treatment options.

Key Fundamentals

EPS-0.99
ROE-445
RPS0.02
ROIC-7.33
ROA-38.42
EBITDA, mln-6.34
EV / EBITDA-52.71
Revenue, mln1.24

Quote Details

Last 0.6499
Change -0.0001 (-0.02%)
Open 0.52
Volume 6,408
Turnover 4,164.56
Average Volume 17,530

Financial Ratios

Pre-Tax Profit Margin-1,393
Current Ratio0.02
Price / Book10.20
Debt / Equity0.00
Price / Sales846

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 41.28% 99 / 100   
1 Month -8.45% 29 / 100   
2 Months 103% 99 / 100   
6 Months 6.75% 74 / 100   
1 Year -72.58% 11 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog